Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Interim trial data for UCB’s bimekizumab shows positive results

pharmatimesAugust 09, 2021

Tag: UCB , bimekizumab , AAD

PharmaSources Customer Service